Elanco jumps after Q1 beat and higher 2026 outlook

Elanco Animal Health Incorporated (ELAN) is up 13.7% today. Here is some analysis on what might have caused this price movement.

Analysis: Shares appear to be rising after Elanco posted strong first-quarter 2026 results and raised full-year guidance, signaling improving operating momentum. The company also lifted its innovation revenue target and tightened its year-end leverage target, which may have supported sentiment around execution and balance-sheet progress.

Details:

Elanco reported first-quarter 2026 revenue of $1.371 billion, up 15% year over year, with 10% organic constant-currency growth.

Adjusted EBITDA was $334 million (24.5% margin) and adjusted EPS was $0.40 for the quarter.

The company raised full-year 2026 guidance ranges for revenue ($5.010 billion to $5.085 billion), adjusted EBITDA ($975 million to $1.005 billion), and adjusted EPS ($1.03 to $1.09).

Elanco also raised its 2026 innovation revenue target to $1.2 billion and improved its year-end net leverage ratio target to 3.0x–3.2x adjusted EBITDA, while highlighting momentum in products such as Zenrelia and Credelio Quattro.

Sources:

Elanco Investor Relations, SEC (EDGAR), The Motley Fool

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$ELAN Insider Trading Activity

$ELAN insiders have traded $ELAN stock on the open market 4 times in the past 6 months. Of those trades, 4 have been purchases and 0 have been sales.

Here’s a breakdown of recent trading of $ELAN stock by insiders over the last 6 months:

JEFFREY N SIMMONS (PRESIDENT, CEO AND DIRECTOR) purchased 22,000 shares for an estimated $478,495
LAWRENCE ERIK KURZIUS purchased 10,000 shares for an estimated $213,000
ROBERT M VANHIMBERGEN (EVP and CFO) purchased 6,950 shares for an estimated $150,426
RAJEEV A. MODI (SEE REMARKS) purchased 4,500 shares for an estimated $95,984

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.

EARLY ACCESS

Receive ELAN Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$ELAN Hedge Fund Activity

We have seen 270 institutional investors add shares of $ELAN stock to their portfolio, and 195 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 14,773,349 shares (-46.9%) from their portfolio in Q4 2025, for an estimated $334,320,887
FMR LLC removed 13,161,059 shares (-20.1%) from their portfolio in Q4 2025, for an estimated $297,834,765
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 4,620,713 shares (-75.2%) from their portfolio in Q4 2025, for an estimated $104,566,735
NUVEEN, LLC removed 3,850,285 shares (-63.2%) from their portfolio in Q1 2026, for an estimated $90,077,417
FREESTONE GROVE PARTNERS LP removed 3,841,422 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $86,931,379
PRIMECAP MANAGEMENT CO/CA/ removed 3,744,068 shares (-7.5%) from their portfolio in Q4 2025, for an estimated $84,728,258
INVESCO LTD. added 3,690,735 shares (+336.0%) to their portfolio in Q4 2025, for an estimated $83,521,333

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$ELAN Analyst Ratings

Wall Street analysts have issued reports on $ELAN in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Keybanc issued a "Overweight" rating on 11/21/2025

To track analyst ratings and price targets for $ELAN, check out Quiver Quantitative's $ELAN forecast page.

$ELAN Price Targets

Multiple analysts have issued price targets for $ELAN recently. We have seen 7 analysts offer price targets for $ELAN in the last 6 months, with a median target of $30.0.

Here are some recent targets:

Daniel Grosslight from Citigroup set a target price of $30.0 on 04/15/2026
Erin Wright from Morgan Stanley set a target price of $24.0 on 02/25/2026
Steve Dechert from Keybanc set a target price of $29.0 on 02/25/2026
Daniel Clark from Leerink Partners set a target price of $30.0 on 02/24/2026
Chris Schott from JP Morgan set a target price of $28.0 on 02/19/2026
David Westenberg from Piper Sandler set a target price of $30.0 on 01/22/2026
Glen Santangelo from Barclays set a target price of $30.0 on 12/09/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.